Immunoproteasome inhibitors
US-12312370-B2 · May 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Brameld Kenneth Albert patents
Brameld Kenneth Albert is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Brameld Kenneth Albert |
| Total patents | 35 |
| First publication | Feb 17, 2015 |
| Latest publication | May 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-12162882-B2 · Dec 10, 2024 · US
Immunoproteasome inhibitors
US-12024531-B2 · Jul 2, 2024 · US
Immunoproteasome Inhibitors
US-2024199655-A1 · Jun 20, 2024 · US
Quinolone Derivatives as Fibroblast Growth Factor Receptor Inhibitors
US-2024092777-A1 · Mar 21, 2024 · US
Immunoproteasome inhibitors
US-11827656-B2 · Nov 28, 2023 · US
Immunoproteasome inhibitors
US-2023133165-A1 · May 4, 2023 · US
Immunoproteasome Inhibitors
US-2022073538-A1 · Mar 10, 2022 · US
Immunoproteasome inhibitors
US-11225493-B2 · Jan 18, 2022 · US
Immunoproteasome inhibitors
US-11154563-B2 · Oct 26, 2021 · US
Recent patents
Latest publications not already listed above.
Quinolone Derivatives as Fibroblast Growth Factor Inhibitors
US-2021292323-A1 · Sep 23, 2021 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-11078199-B2 · Aug 3, 2021 · US
Immunoproteasome inhibitors
US-2020277312-A1 · Sep 3, 2020 · US
LMP7 inhibitors
US-10654843-B2 · May 19, 2020 · US
Quinolone derivatives as FGFR inhibitors
US-10538517-B2 · Jan 21, 2020 · US
Immunoproteasome inhibitors
US-2019336515-A1 · Nov 7, 2019 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-2019233418-A1 · Aug 1, 2019 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-10294223-B2 · May 21, 2019 · US
Lmp7 inhibitors
US-2018208589-A1 · Jul 26, 2018 · US
Quinolone derivatives as fgfr inhibitors
US-2018155340-A1 · Jun 7, 2018 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-2018065960-A1 · Mar 8, 2018 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-9815834-B2 · Nov 14, 2017 · US
Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitors
US-9676778-B2 · Jun 13, 2017 · US
Quinolone derivatives as fibroblast growth factor inhibitors
US-9630963-B2 · Apr 25, 2017 · US
Benzimidazole derivatives as ITK inhibitors
US-9573958-B2 · Feb 21, 2017 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-9567334-B2 · Feb 14, 2017 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-2016229849-A1 · Aug 11, 2016 · US
Quinolone derivatives as fibroblast growth factor receptor inhibitors
US-2016200725-A1 · Jul 14, 2016 · US
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
US-9376438-B2 · Jun 28, 2016 · US
Quinolone derivatives as fibroblast growth factor inhibitors
US-2016130268-A1 · May 12, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Principia Biopharma Inc | 36 |
| Brameld Kenneth Albert | 2 |
| Principia Biopharmac Inc | 1 |
| Goldstein David Michael | 1 |
| Goldstein David M | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 22 |
| A61K45/06 | 20 |
| C07D487/04 | 17 |
| C07D471/04 | 17 |
| A61K31/5377 | 16 |